Tasquinimod
In Stock•Starting at $64 for 10 mg•Purity ≥ 98%
| CAS No. | 254964-60-8 |
|---|---|
| MDL No. | MFCD18251454 |
| MF | C20H17F3N2O4 |
| MW | 406.40 |
| InChI Key | ONDYALNGTUAJDX-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 10 mg | 98% | $64 | In Stock | |
| 25 mg | 98% | $126 | In Stock | |
| 50 mg | 98% | $212 | In Stock | |
| 100 mg | 98% | $358 | In Stock | |
| 250 mg | 98% | $676 | In Stock |
Product Information
Tasquinimod is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic properties. It reduces blood vessel density, though its mechanism of action is unknown. Tasquinimod enhances the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer using human prostate cancer xenografts.
| CAS No. | 254964-60-8 |
|---|---|
| Product Name | Tasquinimod |
Associated Conditions
multiple myeloma·prostate carcinoma·prostate cancer·metastatic prostate cancer·prostate adenocarcinoma
* The information provided here is compiled from public sources and is for reference only.
